Cover Image

The influence of zoledronate and teriparatide on gamma delta T cells in mice

Background/purpose: Few studies have investigated the possibility that bisphosphonate-related osteonecrosis of the jaw (BRONJ) might reflect an immune response; however, gamma delta T cells have been shown to significantly decline in the blood of BRONJ patients. Additionally, there have been some re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eiki Yamachika (Author), Yuichi Matsui (Author), Masakazu Matsubara (Author), Tatsushi Matsumura (Author), Naoki Nakata (Author), Norifumi Moritani (Author), Atsushi Ikeda (Author), Hidetsugu Tsujigiwa (Author), Naoya Ohara (Author), Seiji Iida (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bone regeneration from mesenchymal stem cells (MSCs) and compact bone-derived MSCs as an animal model
by: Eiki Yamachika, et al.
Published: (2013)

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
by: Ruxu You, et al.
Published: (2022)

Profile of teriparatide in the management of postmenopausal osteoporosis
by: Andrea Sikon, et al.
Published: (2010)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
by: Silvia Migliaccio, et al.
Published: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
by: Arthur N Lau, et al.
Published: (2010)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016)

Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022)

Teriparatide in a patient with severe osteoporosis, hypoparathyroidism and thalassemia major
by: Graziani A, et al.
Published: (2022)

The Effect of Teriparatide Treatment on Spinal Deformity Index in Severe Osteoporosis
by: Fatma Gül Ülkü Demir, et al.
Published: (2019)

Effects of teriparatide on bone formation in rats with experimentally induced premaxillary expansion
by: Yasin ÇAMILI, et al.
Published: (2022)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
by: Ruxu You, et al.
Published: (2022)

ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS
by: Rosen Tsolov, et al.
Published: (2020)

Zoledronic Acid-Induced Insulitis in Rats
by: Heresh Rezaei, et al.
Published: (2023)

Inhibition of osteoblast activity by zoledronic acid
by: Fernanda Gonçalves Basso, et al.
Published: (2013)

Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
by: Yang Sun, et al.
Published: (2022)

Enhancement of ghrelin-signaling system by Rikkunshi-To attenuates teriparatide-induced pica in rats
by: Kouichi Yamamoto, et al.
Published: (2018)

First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product
by: Jimena Fernández-Carneado, et al.
Published: (2024)

Zoledronic acid infusion for prevention and treatment of osteoporosis
by: John A Sunyecz
Published: (2010)

Zoledronic acid in the management of metastatic bone disease
by: Thomas J Polascik, et al.
Published: (2008)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
by: Xiang Li, et al.
Published: (2023)

Association between P1NP and bone strength in postmenopausal women treated with teriparatide
by: Fang-Ping Chen, et al.
Published: (2022)

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis
by: Liang Dong, et al.
Published: (2024)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification
by: Jacob KIRBY, et al.
Published: (2024)

Effects of zoledronic acid on osteoblasts in three-dimensional culture
by: Flora Thibaut, et al.
Published: (2015)

How zoledronic acid improves osteoporosis by acting on osteoclasts
by: Biao Wang, et al.
Published: (2022)

Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
by: Chiara Di Pede, et al.
Published: (2016)

Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia
by: Sujit Kumar Tripathy, et al.
Published: (2020)

Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms
by: Chong Li, et al.
Published: (2022)

Pregnancy and gamma/delta T cells: Taking on the hard questions
by: Mincheva-Nilsson Lucia
Published: (2003)

Gamma-delta mycosis fungoides in a posttransplant patient
by: Julie M. Bittar, BA, et al.
Published: (2020)

Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study
by: Akifumi Ijuin, et al.
Published: (2017)

Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
by: Yusuke Zushi, et al.
Published: (2017)

Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury
by: Moliang Xiong, et al.
Published: (2024)

Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
by: Kamimura M, et al.
Published: (2018)

Teriparatide Treatment Following Osteoporotic Hip Fracture in a Male Patient with Multiple Sclerosis and Current Recommendations
by: Sibel Başaran, et al.
Published: (2015)

Intermittent Bi-Daily Sub-cutaneous Teriparatide Administration in Children With Hypoparathyroidism: A Single-Center Experience
by: Julie Bernardor, et al.
Published: (2021)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
by: Ege Can Serefoglu, et al.
Published: (2010)

Polyarthritis following infusion of zoledronic acid: a case study
by: T. Campbell
Published: (2023)

Understanding gamma delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
Published: (2020)